In this sample of older adults, dementia-free at baseline, we found that post-mortem AD pathology, but not LBD or TDP-43 co-pathology, had a greater likelihood of being MBI+ up to 5 years before death versus comparator NPS groups. The gene discussed is TARDBP; the disease is Alzheimer disease.